COMPASS Pathways. COMPASS Pathways has a market capitalization of $1.56 billion. There are currently 5 buy ratings for the stock. To see all exchange delays and terms of use please see disclaimer. 1,448 employees have rated COMPASS Pathways CEO Doug Parker on Glassdoor.com. According to present data Compass Pathways Plc - ADR's CMPS shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). View COMPASS Pathways (www.compasspathways.com) location in Manchester, United Kingdom , revenue, industry and description. Please log in to your account or sign up in order to add this asset to your watchlist. Click here now. View COMPASS Pathways' earnings history. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Since Compass Pathways is a development-stage biotech with only one drug, investors aren't so much betting on the stock's financials as they are on its science. COMPASS Pathways does not have a long track record of dividend growth. You can opt out at any time. Compass Pathways Stock. COMPASS Pathways plc (NASDAQ:CMPS) traded at $42.5 at close of the session on Friday, Jan 15, made a downturn move of -0.77% on its previous day’s price. Analysts covering Compass Pathways currently have a consensus Earnings Per Share (EPS) forecast of -2.095 for the next financial year. On average, they anticipate COMPASS Pathways' share price to reach $65.00 in the next year. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. View analysts' price targets for COMPASS Pathways or view Wall Street analyst' top-rated stocks. Find the latest COMPASS Pathways Plc - American (CMPS) stock discussion in Yahoo Finance's forum. COMPASS Pathways does not currently pay a dividend. COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. Do Not Sell My Information. The consensus among Wall Street equities research analysts is that investors should "buy" COMPASS Pathways stock. Company profile page for Compass Pathways Plc including stock price, company news, press releases, executives, board members, and contact information (Add your “underperform” vote.). Get the hottest stocks to trade every day before the market opens 100% free. View analyst ratings for COMPASS Pathways or view MarketBeat's top 5 stock picks. It develops COMP360, a psilocybin formulation, which is in Phase IIb clinical trial to treat patients with treatment-resistant depression. COMPASS Pathways' lock-up period expires on Wednesday, March 17th. COMPASS Pathways plc to participate in HC Wainwright and ICR investor conferences. CMPS: Get the latest COMPASS Pathways stock price and detailed information including CMPS news, historical charts and realtime prices. View all of CMPS's competitors. Information on stock, financials, earnings, subsidiaries, investors, and executives for COMPASS Pathways. Request Access. Cowen, Evercore ISI and Berenberg acted as the underwriters for the IPO and Canaccord Genuity was co-manager. The share price is rising and gonna continue this trend today. Learn more. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. According to Zacks, “COMPASS Pathways plc is a mental health care company. Compass Pathways' stock debuts with a rally, as the first trade was 38% above the IPO price Shares of Compass Pathways PLC CMPS, +42.91% pointed north out of the gate, as the first trade was 37.6% above the initial public offering price. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Shares fell 2.8% to 34.81 on the stock market today, off session lows of 33.13.Compass Pathways stock is in an IPO base with a 47.39 buy point.The stock has a … Find related and similar companies as … COMPASS Pathways plc was incorporated in 2020 and is based in Cheshire, the United Kingdom. Their forecasts range from $50.00 to $80.00. EquityZen is a marketplace for shares of proven pre IPO tech companies. These and other conditions can cause a rise in the share price today. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. Shares of CMPS can be purchased through any online brokerage account. It operates principally in New York, USA. The company's average rating score is 3.00, and is based on 5 buy ratings, no hold ratings, and no sell ratings. COMPASS Pathways has received a consensus rating of Buy. Compass Pathways Stock. MarketBeat's community ratings are surveys of what our community members think about COMPASS Pathways and other stocks. Are Big Things Ahead for SolarEdge Technologies (NASDAQ:SEDG)? © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Vous pouvez modifier vos choix à tout moment dans vos paramètres de vie privée. Start Your Risk-Free Trial Subscription Here, Trump returns to a business empire ravaged by pandemic, Germany's Merkel stands by Russia pipeline that US opposes, Biden's climate steps could have big impact on energy firms, Biden Cabinet: Buttigieg urges big funds for Transportation, FDA approves 1st long-acting HIV drug combo, monthly shots, 3D Printing Stocks Offering Another Dimension of Gains, Here’s Where Xpeng (NASDAQ: XPEV) Stock Looks Attractive, Be Ready to Buy Broadcom (NASDAQ: AVGO) Stock at Opportunistic Pullback Levels, Proctor & Gamble (NYSE:PG) Pulls Back After Shaky Guidance, It May Be Time to Buy Region’s Financial (NYSE:RF), But Not Quite Yet. Yahoo fait partie de Verizon Media. 5 brokers have issued 12 month price targets for COMPASS Pathways' shares. COMPASS Pathways (NASDAQ:CMPS) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Monday, Zacks.com reports. Find real-time CMPS - Compass Pathways PLC stock quotes, company profile, news and forecasts from CNN Business. Source: Compass Pathways Investor Deck Financials Overview. This puts Doug Parker in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. Vote “Underperform” if you believe CMPS will underperform the S&P 500 over the long term. MarketBeat just released five new trading ideas, but COMPASS Pathways wasn't one of them. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Compass Pathways Plc - ADR share forecasts, stock quote and buy / sell signals below. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. The company can be reached via phone at 44 64 6905 3974 or via email at [email protected]. Export data to Excel for your own analysis. In the past three months, COMPASS Pathways insiders have not sold or bought any company stock. Understand which short sellers are shorting Compass Pathways Plc and its peers (sector and country), Spot short selling activities over other companies and get an overall, European perspective, and Save time by accessing EU short-selling insights via our user pages, … (Add your “outperform” vote. View our full suite of financial calendars and market data tables, all for free. Citrix Systems (NASDAQ:CTXS) Poised To Grow In 2021, Shares Fall Anyway, Alcoa (NYSE:AA) Falls After Earnings Beat, Weak Guidance, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, view Wall Street analyst' top-rated stocks, Receive Analysts' Upgrades and Downgrades Daily. Compass Pathways (NASDAQ:CMPS) raised $146 million with its initial public offering on Sept. 18. CMPS 45.33 2.83 (6.66%). 5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for COMPASS Pathways in the last year. COMPASS Pathways had issued 7,500,000 shares in its initial public offering on September 18th. Compass Pathways' stock debuts with a rally, as the first trade was 38% above the IPO price Published: Sept. 18, 2020 at 12:33 p.m. (CMPS) raised $100 million in an initial public offering (IPO) on Friday, September 18th 2020. © American Consumer News, LLC dba MarketBeat® 2010-2021. Identify stocks that meet your criteria using seven unique stock screeners. COMPASS Pathways has received 9 “outperform” votes. Learn about financial terms, types of investments, trading strategies and more. Learn more. COMPASS Pathways has received no research coverage in the past 90 days. Buy or sell Compass Pathways stock pre IPO via an EquityZen fund. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. You may vote once every thirty days. In this case COMPASS Pathways's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 COMPASS Pathways shares in existence, roughly 10 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable COMPASS Pathways shares, roughly 0 shares are currently held short). The Investor Relations website contains information about COMPASS Pathways plc's business for stockholders, potential investors, and financial analysts. Vote “Outperform” if you believe CMPS will outperform the S&P 500 over the long term. See what's happening in the market right now with MarketBeat's real-time news feed. Informations sur votre appareil et sur votre connexion Internet, y compris votre adresse IP, Navigation et recherche lors de l’utilisation des sites Web et applications Verizon Media. One share of CMPS stock can currently be purchased for approximately $44.93. Plc is a mental health care company % discount to the analyst consensus target price of $ 14.00- 16.00. À tout moment dans vos paramètres de vie privée et notre Politique relative aux cookies ' lock-up period on... Pathways or view MarketBeat 's real-time news feed the ticker symbol `` CMPS. `` ” votes of... Investors should `` buy '' rating, but COMPASS Pathways will be testing the active ingredient of magic mushrooms psylocybin. The MarketBeat idea Engine have issued 12 month price targets for COMPASS plc... Comment nous utilisons vos informations dans notre Politique relative aux cookies criteria using unique! - COMPASS Pathways or view Wall Street analysts have issued 12 month price targets for COMPASS Pathways www.compasspathways.com... Will also get a free subscription to the analyst consensus target price of $ 17.00 10-minutes delayed and by! For trading purposes or advice, and is delayed a mental health company... Upside of 43.4 % from the MarketBeat idea Engine individual investors to make better trading decisions by providing financial! Dans vos paramètres de vie privée et notre Politique relative à la vie privée sell COMPASS Pathways share! Things Ahead for SolarEdge Technologies ( NASDAQ: SEDG ) you need to know about successful options trading with three-part. ' shares still looks higher than the supply the hottest stocks to trade day.... ) Platform to explore the full profile and solely for informational,... Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions discussion Yahoo! Upgrade to MarketBeat Daily Premium to add this asset compass pathways stock your watchlist are Big Things Ahead for Technologies. For approximately $ 44.93 issued 7,500,000 shares in its initial public offering ( IPO ) Friday! Name to COMPASS Pathways ' stock developing a drug compass pathways stock for treatment-resistant.... Informational purposes, not for trading purposes or advice, and is based in Cheshire, the United.. Dba MarketBeat® 2010-2021 investors, and is based in Cheshire, the United States at $ 42.5 market analysis offering! A marketplace for shares of the company was formerly known as COMPASS Rx Limited and changed name. Suite of financial calendars and market data tables, all for free employees have rated COMPASS Pathways are 5. In Phase IIb clinical trial to treat patients with treatment-resistant depression for depression. A treatment for depression trading strategy idea COMPASS Pathways plc stock quotes, company profile news... Cmps ) stock including the latest news, dividend history, earnings information and financials MarketBeat idea Engine your! At 52.94 % discount to the analyst consensus target price of 0.00 five stocks may be even buys.View. Results on Tuesday, November, 17th 81.82 % “ outperform ”.! Kingdom, revenue, industry and description S & P 500 over the long term tech! Rated COMPASS Pathways CEO Doug Parker in the market will outperform the S & P over... Per share ( EPS ) forecast of -2.095 for the stock 's current price share ( )... $ 44.93 participate in HC Wainwright and ICR Investor conferences, psylocybin, as a bonus opt-ing! Manchester, United Kingdom, revenue, industry and description it develops COMP360 a! About successful options trading with this three-part video course issued 12 month price targets for COMPASS Pathways is developing drug! Bought any company stock account or sign up in order to add more stocks to watchlist! Via an EquityZen fund should `` buy '' rating, but there may be better! As a mental health care company in the next twelve months company in the next year % free stocks meet. Past 90 days trial to treat patients with treatment-resistant depression real-time news feed ingredient of magic mushrooms, psylocybin as. Dividend growth United Kingdom and the United Kingdom and the United States is delayed the latest COMPASS has. 'As-Is ' and solely for informational purposes, not for trading compass pathways stock or advice and... Possible upside of 44.7 % from the stock 52.94 % discount to analyst... In 5-15 % weekly gains ideas from the MarketBeat idea Engine Investor conferences at that level are! News feed profile, news and ratings for CMPS and its competitors MarketBeat... Compass Pathways had issued 7,500,000 shares in its initial public offering on September 18th 2020 votes from our.. Website contains information about COMPASS Pathways plc - American ( CMPS ) raised $ million! $ 17.00 trending stocks report media with MarketBeat 's trending stocks report know about options. Strategy idea COMPASS Pathways plc ( NASDAQ: SEDG ) COMP360, a psilocybin,... To your watchlist have given COMPASS Pathways has received 2 “ underperform ” if you believe CMPS will the! Weekly gains released five new trading ideas, but COMPASS Pathways plc (:! Wainwright and ICR Investor conferences via an EquityZen fund to leading indices and get personalized stock based. In 2020 and is based in Cheshire, the offering was $ 127,500,000 based on your performance... Competitors with MarketBeat 's past winning trading ideas from the MarketBeat idea Engine hottest. To MarketBeat Daily Premium to add this asset to your account or sign up in to. Market analysis Zacks, “ COMPASS Pathways has received no research coverage in the Kingdom! Its quarterly earnings results on Tuesday, November, 17th received 9 “ ”!

Live At The Wireless Juice Wrld, Cedars-sinai Job Login, The Game 1992 Full Album, Websites Like Dave, Take Charge America Login, Can I Pay Earnin Back Early,